Abstract

A significant proportion of COVID-19 survivors still experience a reduced diffusion capacity three and twelve months after discharge. We aimed to compare pulmonary function trajectories between hospitalized COVID-19 patients with pre-existing respiratory disease (PRD) and patients without pre-existing respiratory disease (Non-PRD) at three and twelve months after hospital discharge. This single-centre retrospective cohort study included COVID-19 patients admitted to the VieCuri Medical Centre (Venlo, the Netherlands) between February and December 2020 that were invited to the outpatient clinic at three and twelve months after discharge. During this visit, pulmonary function tests were performed and impairments were based on lower limit of normal. Data of 239 patients were analysed (65% male, 66 ± 10 years, and 26% with a history of respiratory disease). Three months after discharge, 49% and 64% of the Non-PRD patients (n = 177) and PRD patients (n = 62) had a low diffusion capacity, respectively. This improved over time in Non-PRD patients (p = 0.003), but not in PRD patients (p = 0.250). A low diffusion capacity was still observed in 34% and 57% of the Non-PRD and PRD group, respectively, twelve months after discharge. Pulmonary function impairments, mainly a reduced diffusion capacity, are observed among hospitalized COVID-19 patients with PRD and Non-PRD, at three and twelve months follow-up. Although diffusion capacity impairments restore over time in Non-PRD patients, poor recovery was observed among PRD patients.

Details

Title
Pulmonary function trajectories in COVID-19 survivors with and without pre-existing respiratory disease
Author
Gach, Debbie 1 ; Beijers, Rosanne J. H. C. G. 2 ; van Zeeland, Roel 3 ; van Kampen-van den Boogaart, Vivian 3 ; Posthuma, Rein 4 ; Schols, Annemie M. W. J. 2 ; van den Bergh, Joop P. 5 ; van Osch, Frits H. M. 6 

 Maastricht University Medical Centre+, Department of Respiratory Medicine, NUTRIM, Institute of Nutrition and Translational Research in Metabolism, Maastricht, The Netherlands (GRID:grid.412966.e) (ISNI:0000 0004 0480 1382); VieCuri Medical Centre, Department of Clinical Epidemiology, Venlo, The Netherlands (GRID:grid.416856.8) (ISNI:0000 0004 0477 5022) 
 Maastricht University Medical Centre+, Department of Respiratory Medicine, NUTRIM, Institute of Nutrition and Translational Research in Metabolism, Maastricht, The Netherlands (GRID:grid.412966.e) (ISNI:0000 0004 0480 1382) 
 VieCuri Medical Centre, Department of Respiratory Medicine, Venlo, The Netherlands (GRID:grid.416856.8) (ISNI:0000 0004 0477 5022) 
 Maastricht University Medical Centre+, Department of Respiratory Medicine, NUTRIM, Institute of Nutrition and Translational Research in Metabolism, Maastricht, The Netherlands (GRID:grid.412966.e) (ISNI:0000 0004 0480 1382); Ciro+, Department of Research and Development, Horn, The Netherlands (GRID:grid.491136.8) (ISNI:0000 0004 8497 4987) 
 VieCuri Medical Centre, Department of Internal Medicine, Venlo, The Netherlands (GRID:grid.416856.8) (ISNI:0000 0004 0477 5022); Maastricht University Medical Centre+, Department of Internal Medicine, NUTRIM, Institute of Nutrition and Translational Research in Metabolism, Maastricht, The Netherlands (GRID:grid.412966.e) (ISNI:0000 0004 0480 1382) 
 VieCuri Medical Centre, Department of Clinical Epidemiology, Venlo, The Netherlands (GRID:grid.416856.8) (ISNI:0000 0004 0477 5022); Maastricht University Medical Centre+, Department of Epidemiology, GROW, Research Institute for Oncology and Reproduction, Maastricht, The Netherlands (GRID:grid.412966.e) (ISNI:0000 0004 0480 1382) 
Pages
16571
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3082045367
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.